Polianta Ltd’s NuVasive, Inc. NUVA Stock Holding History

Polianta Ltd’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-14,300	Closed	-$724K	–	105
2020 Q1	$724K	Buy	+14,300	New	+$959K	0.5%	58

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACA

Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Polianta Ltd's NUVA Position: Q2 2020 in Review

Polianta Ltd sold out of NuVasive, Inc. (NUVA) in Q2 2020, closing a stake of 14,300 shares — an estimated $724K sold.

Polianta Ltd first reported a position in NUVA in Q1 2020 and held it in 1 quarter. The position peaked at $724K in Q1 2020. 290 funds tracked by Wall St. Rank hold NUVA as of Q2 2020.

Polianta Ltd reported no remaining NuVasive, Inc. position as of Q2 2020 after selling out during the quarter.
Polianta Ltd sold 14,300 NuVasive, Inc. shares in Q2 2020, an estimated $724K.
Polianta Ltd first reported a position in NuVasive, Inc. in Q1 2020 and held it in 1 quarter.
Polianta Ltd's NuVasive, Inc. position peaked at $724K in Q1 2020.
290 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2020.

Based on Polianta Ltd's 13F filing for Q2 2020, filed 9 Jul 2020.